UA80512C2 - Process for the manufacture of lysergic acid - Google Patents
Process for the manufacture of lysergic acid Download PDFInfo
- Publication number
- UA80512C2 UA80512C2 UAA200610039A UAA200610039A UA80512C2 UA 80512 C2 UA80512 C2 UA 80512C2 UA A200610039 A UAA200610039 A UA A200610039A UA A200610039 A UAA200610039 A UA A200610039A UA 80512 C2 UA80512 C2 UA 80512C2
- Authority
- UA
- Ukraine
- Prior art keywords
- acid
- lysergic acid
- lysergic
- crystalline
- paspalic
- Prior art date
Links
- ZAGRKAFMISFKIO-QMTHXVAHSA-N lysergic acid Chemical compound C1=CC(C2=C[C@H](CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-QMTHXVAHSA-N 0.000 title claims abstract description 75
- ZAGRKAFMISFKIO-UHFFFAOYSA-N Isolysergic acid Natural products C1=CC(C2=CC(CN(C2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-UHFFFAOYSA-N 0.000 title claims abstract description 74
- 238000000034 method Methods 0.000 title claims description 48
- 238000004519 manufacturing process Methods 0.000 title 1
- RJNCJTROKRDRBW-TZMCWYRMSA-N (6ar,10ar)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinoline-7-ium-9-carboxylate Chemical compound C1=CC([C@H]2C=C(CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 RJNCJTROKRDRBW-TZMCWYRMSA-N 0.000 claims abstract description 46
- RJNCJTROKRDRBW-UHFFFAOYSA-N d-paspalic acid Natural products C1=CC(C2C=C(CN(C2C2)C)C(O)=O)=C3C2=CNC3=C1 RJNCJTROKRDRBW-UHFFFAOYSA-N 0.000 claims abstract description 46
- 229910000000 metal hydroxide Inorganic materials 0.000 claims abstract description 17
- 150000004692 metal hydroxides Chemical class 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 87
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 50
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 34
- 239000002253 acid Substances 0.000 claims description 31
- 238000006317 isomerization reaction Methods 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000011541 reaction mixture Substances 0.000 claims description 16
- 238000005406 washing Methods 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- 239000012452 mother liquor Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 238000002425 crystallisation Methods 0.000 claims description 8
- 230000008025 crystallization Effects 0.000 claims description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 5
- 230000020477 pH reduction Effects 0.000 claims description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 3
- 238000012876 topography Methods 0.000 claims 1
- 239000000047 product Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- HXKPBJXLPCSJBC-BWTUWSSMSA-N (6ar,9r)-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxylic acid;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC(C2=C[C@H](CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 HXKPBJXLPCSJBC-BWTUWSSMSA-N 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 235000005940 Centaurea cyanus Nutrition 0.000 description 2
- 240000004385 Centaurea cyanus Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- KPJZHOPZRAFDTN-ZRGWGRIASA-N (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@H](CO)CC)C2)=C3C2=CN(C)C3=C1 KPJZHOPZRAFDTN-ZRGWGRIASA-N 0.000 description 1
- UNBRKDKAWYKMIV-QWQRMKEZSA-N (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@H](CO)CC)C2)=C3C2=CNC3=C1 UNBRKDKAWYKMIV-QWQRMKEZSA-N 0.000 description 1
- ZAGRKAFMISFKIO-IINYFYTJSA-N (6ar,9s)-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxylic acid Chemical compound C1=CC(C2=C[C@@H](CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-IINYFYTJSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- WVVSZNPYNCNODU-CJBNDPTMSA-N Ergometrine Natural products C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@@H](CO)C)C2)=C3C2=CNC3=C1 WVVSZNPYNCNODU-CJBNDPTMSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- WVVSZNPYNCNODU-XTQGRXLLSA-N Lysergic acid propanolamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@H](CO)C)C2)=C3C2=CNC3=C1 WVVSZNPYNCNODU-XTQGRXLLSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- YSEXMKHXIOCEJA-FVFQAYNVSA-N Nicergoline Chemical compound C([C@@H]1C[C@]2([C@H](N(C)C1)CC=1C3=C2C=CC=C3N(C)C=1)OC)OC(=O)C1=CN=CC(Br)=C1 YSEXMKHXIOCEJA-FVFQAYNVSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- XLMJRFCCCWFQRE-SJRQCXNHSA-N ecboline Chemical compound C([C@H]1[C@]2(O)O3)CCN1C(=O)CN2C(=O)[C@]3(C(C)C)NC(=O)[C@@H](CN(C)[C@@H]1C2)C=C1C1=C3C2=CNC3=CC=C1 XLMJRFCCCWFQRE-SJRQCXNHSA-N 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- 229960001405 ergometrine Drugs 0.000 description 1
- 229960003133 ergot alkaloid Drugs 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229960000328 methylergometrine Drugs 0.000 description 1
- 229960001186 methysergide Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960003642 nicergoline Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000007100 recyclization reaction Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 150000005622 tetraalkylammonium hydroxides Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54655904P | 2004-02-20 | 2004-02-20 | |
| PCT/US2005/004933 WO2005082902A1 (en) | 2004-02-20 | 2005-02-17 | Process for the manufacture of lysergic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA80512C2 true UA80512C2 (en) | 2007-09-25 |
Family
ID=34910787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200610039A UA80512C2 (en) | 2004-02-20 | 2005-02-17 | Process for the manufacture of lysergic acid |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20070135638A1 (ko) |
| EP (1) | EP1718644A1 (ko) |
| JP (1) | JP2007523171A (ko) |
| KR (1) | KR20070024490A (ko) |
| CN (1) | CN1956985A (ko) |
| BR (1) | BRPI0506798A (ko) |
| CA (1) | CA2556774A1 (ko) |
| RU (1) | RU2006133547A (ko) |
| UA (1) | UA80512C2 (ko) |
| WO (1) | WO2005082902A1 (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602007004728D1 (de) * | 2006-06-29 | 2010-03-25 | Ivax Pharmaceuticals Sro | Regulation der säuremetabolitproduktion |
| CN105125481B (zh) * | 2015-08-19 | 2019-01-29 | 河北智同医药控股集团有限公司 | 一种马来酸甲麦角新碱注射液及其制备方法 |
| CN106496220B (zh) * | 2016-10-21 | 2018-05-04 | 重庆乾泰生物医药有限公司 | 一种麦角醇的制备方法 |
| CN106883227B (zh) * | 2017-04-25 | 2018-12-25 | 成都倍特药业有限公司 | 通过麦角菌发酵废料制备麦角新碱的方法 |
| CN111733082A (zh) * | 2020-06-29 | 2020-10-02 | 北大方正集团有限公司 | 一种麦角菌发酵培养基、培养方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB988001A (en) * | 1960-08-19 | 1965-03-31 | Sandoz Ag | Improvements in or relating to lysergic acid derivatives |
| US6242603B1 (en) * | 1999-07-02 | 2001-06-05 | Aventis Pharma S.A. | Process of preparing lysergic acid |
| FR2795728B1 (fr) * | 1999-07-02 | 2001-09-07 | Aventis Pharma Sa | Procede de preparation de l'acide lysergique |
| JP4631129B2 (ja) * | 2000-05-16 | 2011-02-16 | 東ソー株式会社 | テトラブロモビスフェノールａの連続晶析方法 |
| JP2003261548A (ja) * | 2002-03-07 | 2003-09-19 | Teijin Ltd | ２−（３−シアノ−４−イソブチルオキシフェニル）−４−メチル−５−チアゾールカルボン酸の結晶多形体の製造方法 |
-
2005
- 2005-02-17 CN CNA2005800123231A patent/CN1956985A/zh active Pending
- 2005-02-17 UA UAA200610039A patent/UA80512C2/uk unknown
- 2005-02-17 RU RU2006133547/04A patent/RU2006133547A/ru not_active Application Discontinuation
- 2005-02-17 EP EP05723159A patent/EP1718644A1/en not_active Withdrawn
- 2005-02-17 KR KR1020067018668A patent/KR20070024490A/ko not_active Application Discontinuation
- 2005-02-17 CA CA002556774A patent/CA2556774A1/en not_active Abandoned
- 2005-02-17 WO PCT/US2005/004933 patent/WO2005082902A1/en active Application Filing
- 2005-02-17 US US10/589,768 patent/US20070135638A1/en not_active Abandoned
- 2005-02-17 BR BRPI0506798-7A patent/BRPI0506798A/pt not_active IP Right Cessation
- 2005-02-17 JP JP2006554184A patent/JP2007523171A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1718644A1 (en) | 2006-11-08 |
| CN1956985A (zh) | 2007-05-02 |
| JP2007523171A (ja) | 2007-08-16 |
| WO2005082902A1 (en) | 2005-09-09 |
| RU2006133547A (ru) | 2008-03-27 |
| KR20070024490A (ko) | 2007-03-02 |
| CA2556774A1 (en) | 2005-09-09 |
| BRPI0506798A (pt) | 2007-05-22 |
| US20070135638A1 (en) | 2007-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA80512C2 (en) | Process for the manufacture of lysergic acid | |
| IE47910B1 (en) | Optically-active ethers of -cyano-3-phenoxybenzyl alcohol | |
| IE43255B1 (en) | Preparation of an antidepressant | |
| US4294766A (en) | Preparation of pure potassium ribonate and ribonolactone | |
| CA2474646C (en) | Method for production of .beta.-cryptoxanthin and .alpha.-cryptoxanthin from commercially available lutein | |
| DK1682497T3 (en) | PROCEDURE FOR PURIFYING MESOTRION | |
| CN108929284B (zh) | 吗啉酮类异构体的分离方法 | |
| CN116348110A (zh) | 一种盐酸帕罗西汀的纯化方法 | |
| CA2698160C (en) | Stabilized doxercalciferol and process for manufacturing the same | |
| JP2006516148A (ja) | 極性の、好ましくは水性の溶媒から２−ケト−ｌ−グロン酸（ｋｇａ）を抽出する方法 | |
| JPH02121947A (ja) | ２―ケト―ポリヒドロキシ―ｃ↓６―カルボン酸とくに２―ケト―ｌ―グロン酸の水性醗酵排液からの単離法 | |
| CN110590618A (zh) | 一种阿维巴坦中间体的制备方法 | |
| SU831078A3 (ru) | Способ получени цис-изомера ,-ди-МЕТил-9- 3-(4-МЕТил-1-пипЕРАзиНил)пРОпилидЕН -ТиОКСАНТЕН -2-СульфАМидА | |
| CN115991655B (zh) | 一种重酒石酸间羟胺及其关键中间体对映异构体的合成方法和产品 | |
| KR101090047B1 (ko) | 밀베마이신류의 정제법 | |
| CN114736118B (zh) | 一种3-甲氧基-4-羟基扁桃酸分离及其高纯度产物制备方法 | |
| CA2394623C (en) | Process for preparing and isolating 9-deoxo-9(z)-hydroxyiminoerythromycin a | |
| CA2315082A1 (en) | Process for purifying a solution of an ampicillin pro-drug ester | |
| HU186387B (en) | Process for preparing 7alpha-methylthio-17-hydroxy-3-oxo-17alpha-pregn-ene-21-carboxylic acid-gamma lactone | |
| US20010034434A1 (en) | Process for preparing and isolating 9-deoxo-9 (Z)-hydroxyiminoerythromycin A | |
| BE843055R (fr) | Procede de preparation d'un complexe peu soluble de cephalexine | |
| CN110964026A (zh) | N,n—二苯甲氧甲酰大观霉素的制备方法 | |
| CN118791370A (zh) | 一种制备高纯度桧木醇的方法 | |
| KR20000013423A (ko) | 무정형 세푸록심 악세틸의 합성방법 | |
| CN118702662A (zh) | 一种4-甲基-2h-吡喃-2,6(3h)-二酮合成的绿色工艺 |